CATALYST BIOSCIENCES, INC.
Patent Owner
Stats
- 16 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Jan 02, 2018 most recent publication
Details
- 16 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 747 Total Citation Count
- Sep 30, 1999 Earliest Filing
- 9 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9795655 Modified MT-SP1 proteases that inhibit complement activationMay 12, 14Oct 24, 17[A61K, C12N]
9359598 Mutant MT-SP1 proteases with altered substrate specificity or activityMay 20, 13Jun 07, 16[C12N]
9290757 Protease screening methods and proteases identified therebyMay 18, 12Mar 22, 16[A61K, C12Q, C12N, G01N]
8663633 Protease screening methods and proteases identified therebyJul 02, 12Mar 04, 14[A61K, C07H, C12Q]
8519103 Factor VII polypeptides that are modified and uses thereofApr 10, 09Aug 27, 13[A61K, A61P, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0243,855 Modified coagulation factor IX polypeptides and use thereof for treatmentAbandonedNov 14, 12Sep 19, 13[C12N]
2012/0244,139 Modified proteases that inhibit complement activationAbandonedApr 30, 12Sep 27, 12[A61K, A61P]
2010/0166,729 Modified factor VII polypeptides and uses thereofAbandonedApr 11, 08Jul 01, 10[A61K, C12N]
2009/0155,248 Antibodies to MT-SP1 serine proteaseAbandonedJan 14, 08Jun 18, 09[A61K, C12N, G01N, A61P, C07K]
2009/0136,477 Methods of generating and screening for proteases with altered specificityAbandonedDec 28, 07May 28, 09[A61K]
2009/0047,210 Cleavage of VEGF and VEGF receptor by wildtype and mutant MT-SP1AbandonedDec 28, 07Feb 19, 09[A61K, A61P]
2007/0093,443 Modified proteases that inhibit complement activationAbandonedOct 20, 06Apr 26, 07[A61K, C12N]
2006/0029,590 Administration of neutral endopeptidase to treat inflammatory bowel diseaseAbandonedJun 10, 05Feb 09, 06[A61K, C12P, C12N]
2006/0024,289 Cleavage of VEGF and VEGF receptor by wild-type and mutant proteasesAbandonedApr 12, 05Feb 02, 06[A61K, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.